For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI ...

A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.

Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for ...

There is varicella-zoster virus reactivation in cerebrospinal fluid in a fifth of patients following acute ischemic stroke or TIA.

The International Advisory Committee on Clinical Trials led a multinational panel updating the McDonald criteria, adding the ...

The McDonald criteria revisions provide a unified approach for diagnosing MS from pediatric to late-life presentations, said ...

Health ministry advisory urges rational use of cough syrups in children after 11 deaths in Madhya Pradesh and Rajasthan.

This test is available exclusively through CNSide Diagnostics, LLC. as a testing service provided to health care professionals in the U.S.

A simple blood test measuring neurofilament light chain, or NfL levels, may help predict the risk of developing brain diseases years before symptoms appear, according to neurologists. Elevated NfL ...

CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with ...

A new Lancet review proposes a three-wave diagnostic pathway that combines clinical expertise with blood, CSF, and PET ...